Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.960
-0.040 (-2.00%)
At close: Feb 21, 2025, 4:00 PM
2.000
+0.040 (2.04%)
After-hours: Feb 21, 2025, 4:47 PM EST
Boundless Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
72
Market Cap
43.71M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBOLD News
- 19 days ago - Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer - GlobeNewsWire
- 2 months ago - Boundless Bio Announces Pipeline and Leadership Updates - GlobeNewsWire
- 3 months ago - Boundless Bio to Participate in the Piper Sandler Healthcare Conference - GlobeNewsWire
- 3 months ago - Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 3 months ago - Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference - GlobeNewsWire
- 5 months ago - Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 6 months ago - Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 9 months ago - Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - Business Wire